NB-4746
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NB-4746, covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis. [Phase 1, Phase 2]